Evidence map›Paper›PMID 39439635›Full record

ArticleCureus2024

A Rare Case of Neuropathic Pain in Cutis Verticis Gyrata: A Review of Contemporary Literature.

Vaibhav Oberoi, Kevin Morris, Inderjit Singh, Apindervir Kaur Mann, Gurpreet Kaur

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vaibhav OberoiDepartment of Neurology, Government Medical College and Hospital, Amritsar, Amritsar, IND.
Kevin MorrisResearch, Society for Brain Mapping and Therapeutics, Los Angeles, USA.
Inderjit SinghDepartment of Neurology, Government Medical College and Hospital, Amritsar, Amritsar, IND.
Apindervir Kaur MannDepartment of Internal Medicine, Government Medical College and Hospital, Amritsar, Amritsar, IND.
Gurpreet KaurDepartment of Internal Medicine, Government Medical College and Hospital, Amritsar, Amritsar, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutis verticis gyrata (CVG) is a rare benign neurocutaneous condition marked by thickened scalp folds resembling cerebral gyri and sulci. It has been classified into primary essential, primary non-essential, and secondary types. The primary essential type is idiopathic, and the primary non-essential type may be associated with neurological or ophthalmological complications. Secondary CVG occurs more commonly than primary CVG, affects both genders at any age, and can be associated with endocrinal disorders, tumors, inflammatory diseases, or genetic conditions. For every 38.46 male cases, only one female case is known. This report aims to inform about a rare case of primary CVG in a 35-year-old female patient presenting with neuropathic pain localized to the affected area, a complication not previously documented in the literature. Heightened sensitivity to light touch and pinprick sensation in the high parietal scalp region was indicative of neuropathic pain. This report also highlights the importance of a multidisciplinary approach to treatment, including pharmacological treatment modalities such as analgesics and non-pharmacological management such as desensitization techniques and physical therapy. Critically, it is necessary to regularly follow up and perform proper clinical evaluation and screening to improve the quality of life for patients with CVG.

Indexed as

cutis verticis gyrata (cvg)dermatologymultimodal pain managementneurocutaneous disorderneurological complicationneuropathic painscalp deformity

Identifiers

PMID39439635
PMCPMC11495886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.